Immunicum: Patent application related to Immunicum's therapeutic cancer ...
25.1.15
Add Comment
Immunicum: Patent application related to Immunicum's therapeutic cancer ...
The vector makes it possible to charge Immunicum's therapeutic cancer vaccine SUBCUVAX with several different tumor antigens. SUBCUVAX does not require access to an injectable tumor but can be injected under the skin (subcutaneously). Another use ...
Read more on GlobeNewswire (press release)
Research and Markets: Dendritic Cell Cancer Vaccine Market & Clinical Insight ...
The high pace of research and development along with initial positive results in experimental studies is expected to create large market for dendritic cell based cancer vaccines. The design of dendritic cell cancer vaccine is likely to improve and much ...
Read more on Business Wire (press release)
The vector makes it possible to charge Immunicum's therapeutic cancer vaccine SUBCUVAX with several different tumor antigens. SUBCUVAX does not require access to an injectable tumor but can be injected under the skin (subcutaneously). Another use ...
Read more on GlobeNewswire (press release)
Research and Markets: Dendritic Cell Cancer Vaccine Market & Clinical Insight ...
The high pace of research and development along with initial positive results in experimental studies is expected to create large market for dendritic cell based cancer vaccines. The design of dendritic cell cancer vaccine is likely to improve and much ...
Read more on Business Wire (press release)
0 Response to "Immunicum: Patent application related to Immunicum's therapeutic cancer ..."
Post a Comment